AUTOIMMUNITY part 75

Immune 4

 

THE FUTURE

THERAPY DIRECTED AT INFLAMMATORY PATHWAYS

The pace of changes in the field of autoimmunity is rapid. Recent advances in understanding the importance of key inflammatory pathways involved  in specific diseases, such as the TNF-α pathway in RA, inflammatory bowel disease, and other disorders, but have been quickly followed by new biological therapies designated to interfere with these pathways. With recent data increasingly underscoring the importance of type I interferon pathways in the pathogenesis of lupus, it seems reasonable to expect that therapies directed at preventing the excessive production of IFN-α/-β will be tested in the near future. As always, a major  challenge in immune therapy will be to treat  the key immunological defects  selectively,  leaving the remainder pf the immune system intact to deal with infections. As the important immunological pathways become better defined, it may be feasible  to selectively target one part of the pathway while   leaving other intact. For instance, type I interferon is produced through several interrelated pathways. If only one of them is found to be abnormal in SLE, it may be feasible to selectively blockade that pathway, leaving the others intact to deal with viral and other infections.

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s